Shedding light on corticosteroid-resistant type 2-high severe asthma

Affiliations

¹ National Heart & Lung Institute, Imperial College London & Royal Brompton and Harefield NHS Trust, London, United Kingdom. Electronic address: f.chung@imperial.ac.uk.

Editorial

Kian Fan Chung. J Allergy Clin Immunol. 2019 Jan.

. 2019 Jan;143(1):89-90.

doi: 10.1016/j.jaci.2018.11.002. Epub 2018 Nov 14.

¹ National Heart & Lung Institute, Imperial College London & Royal Brompton and Harefield NHS Trust, London, United Kingdom. Electronic address: f.chung@imperial.ac.uk.

No abstract available

Keywords: Asthma; corticosteroid resistance; eosinophils; type 2 inflammation.

Comment on

Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids.
Peters MC, Kerr S, Dunican EM, Woodruff PG, Fajt ML, Levy BD, Israel E, Phillips BR, Mauger DT, Comhair SA, Erzurum SC, Johansson MW, Jarjour NN, Coverstone AM, Castro M, Hastie AT, Bleecker ER, Wenzel SE, Fahy JV; National Heart, Lung and Blood Institute Severe Asthma Research Program 3. Peters MC, et al. J Allergy Clin Immunol. 2019 Jan;143(1):104-113.e14. doi: 10.1016/j.jaci.2017.12.1009. Epub 2018 Mar 7. J Allergy Clin Immunol. 2019. PMID: 29524537 Free PMC article.